| Sacubitril-Valsartan-Mepha 97 mg/103 mg, Filmtabletten - 168 | | 69813006 | | Mepha Pharma AG | | Sacubitril-Valsartan-Mepha 97 mg/103 mg, Filmtabletten | | 11.12.2025 | | | | | 11.12.2025 | | Valsartan and Sacubitril (C09DX04) | | | | WHO-DDD | | 10.12.2030 | | | | 168 | | 02.07.20. | | | | | | | | Nein | | | | | | | | | | | | k.A. | | | | FB | | | | 7680698130062 | | Synthetika | | | | |
| | Zusammensetzung | | Filmtablette: sacubitrilum 97.20 mg ut sacubitrilum natricum, valsartanum 102.80 mg ut valsartanum dinatricum, cellulosum microcristallinum, talcum, hydroxypropylcellulosum substitutum humile, crospovidonum, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 4000, E 171, E 172 (rubrum), E 172 (nigrum), pro compresso obducto corresp. natrium 16.284 mg. | | Packungsbestandteile | | Filmtabletten | | | | Wirkstoffe | Stärke | Zusätzliche Information |
|---|
| Sacubitrilum | 97.2 mg | Filmtablette | | Valsartan | 102.8 mg | |
| | | | Hilfsstoffe | Stärke | Zusätzliche Information |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum Substitutum Humile | | | | Hypromellosum | | Überzug | | Macrogol | 4000 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Talcum | | |
|
| | Quelle | | | |
|
|
